Andreas Katopodis

Outlook Microsoft Office 365 Salesforce WordPress.org Google Tag Manager Vimeo reCAPTCHA Google Analytics Nginx Mobile Friendly

immunotherapy oncology cytokines biotechnology research immuno-oncology cytokine-based therapies immune response modulation drug development clinical trials tumor microenvironment checkpoint inhibitors il-2 receptor biologics targeted therapies cancer treatment t-cell activation cd8+ t cells transplantation protein engineering therapeutic antibodies preclinical development clinical-stage biopharmaceuticals autoimmune diseases antibody fusion proteins immune-mediated diseases tumor antigens biopharmaceutical innovation cancer immunotherapy precision medicine pd-1 inhibitors cellular therapies tumor-specific therapies translational medicine phase i/ii trials safety profile novel therapies patient outcomes tumor infiltration lymphocytes il-21 therapies immune tolerance il-2 agonists immune checkpoint inhibitors biopharma partnerships investor funding discovery pipeline therapeutic development ex vivo studies safety & efficacy calineurin inhibitors multispecific antibodies hospital & health care health care health wellness & fitness